Search

Your search keyword '"C. Maugard"' showing total 112 results

Search Constraints

Start Over You searched for: Author "C. Maugard" Remove constraint Author: "C. Maugard"
112 results on '"C. Maugard"'

Search Results

1. Modalités et morbidité des mastectomies de réduction de risque en dehors du risque avéré de prédisposition héréditaire : recommandations du Collège national des gynécologues et obstétriciens français (CNGOF)

2. Clinical performance evaluation of Elecsys HIV Duo, Anti-HCV II, HBsAg II, Anti-HBc II, and Syphilis assays for routine screening of first-time blood donor samples at a French blood donation center

3. Syndrome de Muir-Torre chez un patient atteint de maladie de Waldenström

4. [Muir-Torre syndrome associated with Waldenstrom's macroglobulinemia]

6. HIGH GRADE GLIOMAS AND DIPG

8. Marker segregation information in breast/ovarian cancer genetic counseling: Is it still useful?

9. French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours

10. Attitudes towards cancer predictive testing and transmission of information to the family

11. Cancer genetics clinics: Target population and consultees' expectations

12. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain

13. Abstracts

14. Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group

15. Cancer genetic clinics: why do women who already have cancer attend?

16. Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer

17. A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy

18. Pathology of sporadic breast tumors with LOH at the BRCA1 locus: correlation with histopathological features specific to familial BRCA1 tumors and absence of microsatellite instability

19. 116 Higher incidence of patients with a positive family history of prostate cancer than expected amongst French Canadians

20. French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris

21. BRCA2 mutations in hereditary breast and ovarian cancer in France

22. Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium

23. A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC

24. Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity

25. [Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy]

26. [Well-differentiated papillary mesothelioma of the peritoneum: an attenuated malignant tumor. Review of the literature apropos of a case]

27. Leptomeningeal infiltration in esthesioneuroblastoma: report of two cases with poor prognosis

28. [Cancer of the breast]

29. [Genetics and cancers]

30. Risk Model for Severe Anemia Requiring Red Blood Cell Transfusion After Cytotoxic Conventional Chemotherapy Regimens

31. Le test de troncation des protéines (PTT) : un outil pour la détection de mutations dans l'ADN

32. Anthracycline as second line chemotherapy (CT) for metastatic breast cancer (MBC) patients previously treated with taxotere (TXT)

34. 970 An evaluation of the neurotoxicity of a phase I dose finding study of docetaxel (D) in combination with vinorelbin (V)

35. Study of 2 doses of granulocyte colony stimulating factor (G-CSF): PE 2601 in patients (PTS) with advanced breast carcinoma (ABC) treated by intensive chemotherapy

37. Giant cell arteritis in a conjugal pair

38. Time elapsing from cancer diagnosis and anxiety in women attending cancer genetic clinics

39. A pilot rating system to evaluate the quality of goal attainment scales used as outcome measures in rehabilitation.

40. Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectives.

41. Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France.

42. Insights on 21 Years of HBV Surveillance in Blood Donors in France.

43. The TRACTOR Project: TRACking and MoniToring Occupational Risks in Agriculture Using French Insurance Health Data (MSA).

44. Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in France.

45. Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I.

46. [Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)].

47. Clinical performance evaluation of Elecsys HIV Duo, Anti-HCV II, HBsAg II, Anti-HBc II, and Syphilis assays for routine screening of first-time blood donor samples at a French blood donation center.

48. Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

50. National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract.

Catalog

Books, media, physical & digital resources